What are the responsibilities and job description for the Sr Mgr/Associate Director, Clinical Demand Planning & Forecasting position at Kura Oncology?
Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.
At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.
As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.
To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.
ESSENTIAL JOB FUNCTIONS :
- Responsible for leading and developing drug supply planning strategy and overall management of all aspects of drug supplies (IP) for global FIH - Phase I - III clinical studies as the leader of Investigational Medicinal Supply Chain (IMSC).
- Must be flexible and agile to review, determine and execute the impact of protocol design changes, whether before study launch or during study execution and relay the impact to IMSC, CMC and other key customers.
- Understand and incorporate non-clinical demands into overall Demand Planning and Forecasting output, to support approved requirement like but not limited to Investigator Sponsored Studies (ISS), Early Access Programs (EAP), Compassionate Use (CU) etc.
- Responsible for providing strategic leadership of IMSC Demand Planning and Forecasting, and demonstrating operational excellence and interdependent workflows with CMC, Analytical Development, Quality Assurance, etc.
- Establish operating policies and procedures and provide comprehensive coordination of complex global supply chain operations, inventories, materials, and procurement while ensuring compliance with regulations and guidelines.
- Maintain expert-level understanding of IRT systems, to monitor on-going protocol enrollment, issuances, time-on-therapy to verify actuals versus projections, determine trends, execute adjustments, and communicate and changes to deliverables promptly and concisely.
- Manage extensive internal and external touchpoints and maintain close communications with all IMSC groups to ensure the adequate supply of clinical supplies throughout the duration of multiple WW clinical trials including oversight of drug order requests, resupply, and processes.
- Contribute and participate in the upkeep and maintenance of IMSC as it relates to SOP, Work Instructions and other key processes and procedures.
JOB SPECIFICATIONS :
The base range for a Senior Manager is $134,875 - $158,079 and an Associate Director is $156,750 - $186,954 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.
Kura's Values that are used for candidate selection and performance assessments :
The Kura Package
Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company's diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology's approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.
Kura's pipeline consists of three investigational drug candidates : ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R / R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R / R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R / R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1 / 2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura's website at www.kuraoncology.com and follow us on X and LinkedIn .
Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
Salary : $156,750 - $186,954
